Literature DB >> 28260051

MicroRNA-1 upregulation promotes myocardiocyte proliferation and suppresses apoptosis during heart development.

Liping Liu1, Yonghua Yuan1, Xuehua He1, Xiaohui Xia2, Xiaoyang Mo3.   

Abstract

Previous studies have investigated the role of microRNAs (miRs) in heart development to reveal the miRNA mechanism of action in congenital heart disease (CHD) in children. The present study aimed to investigate the role of miR‑1 in heart development in P19 cells. The mRNA level for miR‑1 in P19 cells was detected before or after cardiomyocyte differentiation, using reverse transcription‑quantitative polymerase chain reaction analysis. Expression of cardiomyocyte differentiation markers was also analyzed. The effect of miR‑1 overexpression on the viability and apoptosis of differentiated P19 cells was assessed using MTT and Annexin V‑FITC assays, respectively. Furthermore, the effects of miR-1 on expression of markers of cell proliferation and apoptosis were also analyzed in differentiated P19 cells using western blotting. The results demonstrated that P19 cells were successfully differentiated into cardiomyocytes, and that endogenous miR‑1 expression was significantly decreased in differentiated P19 cells compared with undifferentiated P19 cells. Overexpression of miR‑1 resulted in increased viability in differentiated P19 cells and decreased apoptosis, compared with the normal control. In addition, expression of heart and neural crest derivatives expressed transcript 2 (Hand2) was increased in differentiated cells with miR‑1 overexpressed compared with normal cells, while caspase‑3 cleavage was decreased by miR‑1 overexpression. In conclusion, the present study suggested that miR-1 upregulation may be important in regulating cell proliferation and apoptosis in P19 differentiated cardiomyocytes by increasing Hand2 expression and suppressing caspase‑3 cleavage. The present study aimed to provide a theoretical basis for the explanation of the mechanism of CHD and investigate miR‑1 as a potential therapeutic target for its clinical treatment.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28260051     DOI: 10.3892/mmr.2017.6282

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  microRNA-1 inhibits cardiomyocyte proliferation in mouse neonatal hearts by repressing CCND1 expression.

Authors:  Jingyi Gan; Florence Mei Kuen Tang; Xianwei Su; Gang Lu; Jing Xu; Henry Siu Sum Lee; Kenneth Ka Ho Lee
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Identification of differential microRNAs and messenger RNAs resulting from ASXL transcriptional regulator 3 knockdown during during heart development.

Authors:  Ze-Qun Liu; Mi Cheng; Fang Fu; Ru Li; Jin Han; Xin Yang; Qiong Deng; Lu-Shan Li; Ting-Ying Lei; Dong-Zhi Li; Can Liao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 3.  Direct reprogramming of fibroblasts into cardiomyocytes.

Authors:  Yueqiu Chen; Ziying Yang; Zhen-Ao Zhao; Zhenya Shen
Journal:  Stem Cell Res Ther       Date:  2017-05-25       Impact factor: 6.832

4.  MiR-499 inhibited hypoxia/reoxygenation induced cardiomyocytes injury by targeting SOX6.

Authors:  Yujie Shi; Yunfeng Han; Lili Niu; Junxia Li; Yundai Chen
Journal:  Biotechnol Lett       Date:  2019-05-10       Impact factor: 2.461

Review 5.  Post-Transcriptional Regulation of Molecular Determinants during Cardiogenesis.

Authors:  Estefania Lozano-Velasco; Carlos Garcia-Padilla; Maria Del Mar Muñoz-Gallardo; Francisco Jose Martinez-Amaro; Sheila Caño-Carrillo; Juan Manuel Castillo-Casas; Cristina Sanchez-Fernandez; Amelia E Aranega; Diego Franco
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

6.  Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects.

Authors:  Yiru Yang; Hainan Yang; Xihua Lian; Shuping Yang; Haolin Shen; Shufen Wu; Xiali Wang; Guorong Lyu
Journal:  Front Genet       Date:  2022-08-11       Impact factor: 4.772

7.  MicroRNA expression profiling involved in doxorubicin-induced cardiotoxicity using high-throughput deep-sequencing analysis.

Authors:  Ying Chen; Yingjie Xu; Zhoufeng Deng; Yin Wang; Ying Zheng; Weihua Jiang; Li Jiang
Journal:  Oncol Lett       Date:  2021-05-26       Impact factor: 2.967

8.  Perindopril Improves Cardiac Function by Enhancing the Expression of SIRT3 and PGC-1α in a Rat Model of Isoproterenol-Induced Cardiomyopathy.

Authors:  Zhenyu Zhu; Huihui Li; Wanli Chen; Yameng Cui; Anan Huang; Xin Qi
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.